Bayer & Monsanto

Now Advancing Together as One

read more
Now Advancing Together as One

Explore Your Topic

Latest News

Share Price/Index

Local News

September 18, 2018

New indication will help Canadians with coronary artery disease prevent heart attack, stroke or death

Rivaroxaban (XARELTO®) 2.5 mg twice daily in combination with acetylsalicylic acid (ASA) 75 mg -100 mg once daily offers a new way to treat Canadians with coronary artery disease Read more
July 17, 2018

Bayer launches Olympus, the premier pre-seed foxtail barley solution for growers across the Prairies

Read more
June 07, 2018

Bayer closes Monsanto acquisition

Read more
Bayer News Overview

Global News

September 13, 2018

Stefan Oelrich to join Bayer Board of Management and head Pharmaceuticals Division

Read more

Our Businesses

We research, develop and market innovative products that improve the health of people, plants and animals. Our business comprises three core divisions and two business units. Learn more about it here.

Last updated: September 11, 2018